These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23497601)
21. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. de Wijkerslooth TR; de Haan MC; Stoop EM; Deutekom M; Fockens P; Bossuyt PM; Thomeer M; van Ballegooijen M; Essink-Bot ML; van Leerdam ME; Kuipers EJ; Dekker E; Stoker J BMC Gastroenterol; 2010 May; 10():47. PubMed ID: 20482825 [TBL] [Abstract][Full Text] [Related]
22. Cost analysis of colorectal cancer screening with CT colonography in Italy. Mantellini P; Lippi G; Sali L; Grazzini G; Delsanto S; Mallardi B; Falchini M; Castiglione G; Carozzi FM; Mascalchi M; Milani S; Ventura L; Zappa M Eur J Health Econ; 2018 Jun; 19(5):735-746. PubMed ID: 28681075 [TBL] [Abstract][Full Text] [Related]
23. What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Walleser S; Griffiths A; Lord SJ; Howard K; Solomon MJ; Gebski V Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1439-46; quiz 1368. PubMed ID: 18054752 [TBL] [Abstract][Full Text] [Related]
24. Medicare cost of colorectal cancer screening: CT colonography vs. optical colonoscopy. Pyenson B; Pickhardt PJ; Sawhney TG; Berrios M Abdom Imaging; 2015 Oct; 40(8):2966-76. PubMed ID: 26350285 [TBL] [Abstract][Full Text] [Related]
25. Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials). Halligan S; Dadswell E; Wooldrage K; Wardle J; von Wagner C; Lilford R; Yao GL; Zhu S; Atkin W Health Technol Assess; 2015 Jul; 19(54):1-134. PubMed ID: 26198205 [TBL] [Abstract][Full Text] [Related]
26. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M; J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer. Kuntz KM; Popp J; Beck JR; Zauber AG; Weinberg DS BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32933928 [TBL] [Abstract][Full Text] [Related]
28. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study. Lisi D; Hassan C; Crespi M; Dig Liver Dis; 2010 May; 42(5):371-6. PubMed ID: 19747888 [TBL] [Abstract][Full Text] [Related]
29. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404 [TBL] [Abstract][Full Text] [Related]
30. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087 [TBL] [Abstract][Full Text] [Related]
31. Contribution of the OC Sensor Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183 [TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of screening strategies for colorectal cancer. Barzi A; Lenz HJ; Quinn DI; Sadeghi S Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881 [TBL] [Abstract][Full Text] [Related]
33. Options for screening for colorectal cancer. Atkin W Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674 [TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years. Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905 [TBL] [Abstract][Full Text] [Related]
35. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
36. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Multicentre Australian Colorectal-neoplasia Screening (MACS) Group Med J Aust; 2006 Jun; 184(11):546-50. PubMed ID: 16768659 [TBL] [Abstract][Full Text] [Related]
37. CT colonography after incomplete colonoscopy in subjects with positive faecal occult blood test. Sali L; Falchini M; Bonanomi AG; Castiglione G; Ciatto S; Mantellini P; Mungai F; Menchi I; Villari N; Mascalchi M World J Gastroenterol; 2008 Jul; 14(28):4499-504. PubMed ID: 18680229 [TBL] [Abstract][Full Text] [Related]
38. CT colonography versus colonoscopy for the detection of advanced neoplasia. Kim DH; Pickhardt PJ; Taylor AJ; Leung WK; Winter TC; Hinshaw JL; Gopal DV; Reichelderfer M; Hsu RH; Pfau PR N Engl J Med; 2007 Oct; 357(14):1403-12. PubMed ID: 17914041 [TBL] [Abstract][Full Text] [Related]
39. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M; J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571 [TBL] [Abstract][Full Text] [Related]